Article Details
Retrieved on: 2025-04-29 16:53:41
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Switching between anti-CGRP monoclonal antibodies (mAbs) significantly reduced monthly headache days (MHDs) in patients with migraine who did not ...
Article found on: www.patientcareonline.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here